These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Off-label use of aducanumab for cerebral amyloid angiopathy. Greenberg SM; Cordonnier C; Schneider JA; Smith EE; van Buchem MA; van Veluw SJ; Verbeek MM; Viswanathan A; Werring DJ Lancet Neurol; 2021 Aug; 20(8):596-597. PubMed ID: 34237272 [No Abstract] [Full Text] [Related]
8. Vessels Sing Their ARIAs: The Role of Vascular Amyloid in the Age of Aducanumab. Sveikata L; Charidimou A; Viswanathan A Stroke; 2022 Jan; 53(1):298-302. PubMed ID: 34905943 [TBL] [Abstract][Full Text] [Related]
9. Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies. Boncoraglio GB; Piazza F; Savoiardo M; Farina L; DiFrancesco JC; Prioni S; Tagliavini F; Parati EA; Giaccone G J Alzheimers Dis; 2015; 45(2):363-7. PubMed ID: 25537009 [TBL] [Abstract][Full Text] [Related]
10. APOE {epsilon}4 and bapineuzumab: Infusing pharmacogenomics into Alzheimer disease therapeutics. Kaufer D; Gandy S Neurology; 2009 Dec; 73(24):2052-3. PubMed ID: 19923549 [No Abstract] [Full Text] [Related]
11. Alzheimer's drugs take a new tack. Callaway E Nature; 2012 Sep; 489(7414):13-4. PubMed ID: 22962697 [No Abstract] [Full Text] [Related]
12. Low avidity and level of serum anti-Aβ antibodies in patients with cerebral amyloid angiopathy-related cerebral hemorrhage. Cao Z; Lv J; Quan W Int J Neurosci; 2010 Dec; 120(12):760-4. PubMed ID: 20954837 [TBL] [Abstract][Full Text] [Related]
13. [Vaccination against Alzheimer disease?]. Blasko I; Grubeck-Loebenstein B Wien Klin Wochenschr; 2003 May; 115(9):279-80. PubMed ID: 12793027 [No Abstract] [Full Text] [Related]
14. Amyloid antibody therapy for early-stage Alzheimer's disease: a critical review of three recent trials. Guiloff AE; Rudge P J Neurol; 2024 May; 271(5):2914-2916. PubMed ID: 38613568 [No Abstract] [Full Text] [Related]
15. Gantenerumab for the treatment of Alzheimer's disease. Delrieu J; Ousset PJ; Vellas B Expert Opin Biol Ther; 2012 Aug; 12(8):1077-86. PubMed ID: 22583155 [TBL] [Abstract][Full Text] [Related]